Aims and Scope
The Journal of Mass Spectrometry and Advances in the Clinical Lab (JMSACL) is an open access journal that publishes peer-reviewed articles addressing mass spectrometry and OTHER advances in Laboratory Medicine and Pathology with a focus on development of diagnostic and related applications, including data science, to improve patient outcomes and reduce healthcare costs. Submissions are NOT restricted to mass spectrometry as an analysis technique.
Beyond communication of the application of technologies in the routine clinical diagnostic setting, by publishing critically validated analytical protocols, the journal also addresses the translation of experimental techniques and analytical research into patient care, and the use of these technologies in clinical research and routine patient management. The scope of the journal is not restricted to any particular technology, but covers the entire range of technologies and advancements that are expected to impact the clinical lab.
The journal encourages submissions that have a clear path to patient care, including basic and translational research, and animal studies.
Subject Areas covered, but not restricted to:
- Automation
- Clinical Studies and Implementation
- Cross-Technology Investigations
- Data Science
- Endocrinology
- Error Sources, Risk Assessment and Patient Safety
- Glycomics
- Harmonization and Standardization
- Imaging
- Instrumentation
- Lipidomics
- Metabolomics and Metabolic Analyses
- Method Development and Validation
- Metrology
- Microbiology
- Neonatal Screening
- New Technologies
- Point-of-Care Technologies
- Protein Quantification
- Protein Variant Detection
- Proteomics
- Quality Management
- Reference Methods and Materials
- Regulatory Aspects in Diagnostic Applications
- Sample Preparation
- Separation Science
- Small Molecules
- Spatialomics
- Therapeutic Drug Monitoring
- Toxicology
